Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 September 2019 | Story Xolisa Mnukwa | Photo Xolisa Mnukwa
Koffie Yinkah
“I believe the Hesselbein Global Academy annual fellowship programme was vital for me as a potential public servant of South Africa to serve the people of this country in government one day.” – Kofi Yinkah

University of the Free State (UFS) third-year BAdmin student, Kofi Annan Yinkah, formed part of the Hesselbein Global Academy annual fellowship programme, hosted by the University of Pittsburgh in the United States of America (USA). Originally from the East Rand in Johannesburg, Kofi represented the UFS as one of the top-50 students who were selected out of 450 global applicants.

The Hesselbein Global Academy annual fellowship programme aims to connect young leaders from all over the world with well-equipped professionals who are leaders in the fields of business, government, and education. This programme was established for the purpose of cultivating and producing cadres who will become experienced ethical leaders, armed and qualified enough to address and solicit solutions for critical issues experienced by diverse societies throughout the world.

“The fellowship covered topics that have helped to broaden my critical thought processes and concerns about societal issues in our country and all over the world. It has also emphasised the importance of implementing change through effective governing-policy development and establishment,” Kofi says.

He describes his experience at the fellowship as “out of the ordinary,” and believes that it has had a progressive influence on his life. He explains how it has unlocked his mind through enlightened engagement with student leaders from various countries in the world, including Nigeria, England, Canada, Chile, Trinidad and Tobago, Vietnam, China, United States of America, and Ireland.

One of the most important tools he believes his experience has equipped him with, is understanding the significance of employing a solution-driven approach to various situations. He is confident that this will give him the necessary skills and knowledge to work effectively in teams.

Kofi explains that he found out about the fellowship programme via social media. He encourages UFS students to use online platforms to source information about opportunities that can offer them meaningful experiences for learning and growing. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept